Cargando…

Functional genomics for breast cancer drug target discovery

Breast cancer is a heterogeneous disease that develops through a multistep process via the accumulation of genetic/epigenetic alterations in various cancer-related genes. Current treatment options for breast cancer patients include surgery, radiotherapy, and chemotherapy including conventional cytot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshimaru, Tetsuro, Nakamura, Yusuke, Katagiri, Toyomasa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384626/ https://www.ncbi.nlm.nih.gov/pubmed/34285339 http://dx.doi.org/10.1038/s10038-021-00962-6

Ejemplares similares

Therapeutic advances in BIG3-PHB2 inhibition targeting the crosstalk between estrogen and growth factors in breast cancer
por: Yoshimaru, Tetsuro, et al.
Publicado: (2015)

Targeting BIG3–PHB2 interaction to overcome tamoxifen resistance in breast cancer cells
por: Yoshimaru, Tetsuro, et al.
Publicado: (2013)

Infrequent Mutation of the H‐Cadherin Gene on Chromosome 16q24 in Human Breast Cancers
por: Miki, Yoshio, et al.
Publicado: (1997)

Xanthohumol suppresses oestrogen-signalling in breast cancer through the inhibition of BIG3-PHB2 interactions
por: Yoshimaru, Tetsuro, et al.
Publicado: (2014)

Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (BIG3) is predicted to interact with its partner through an ARM-type α-helical structure
por: Chen, Yi-An, et al.
Publicado: (2014)

Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeutics
por: Yoshimaru, Tetsuro, et al.
Publicado: (2017)

Genome-Wide Association Study of Breast Cancer in the Japanese Population
por: Low, Siew-Kee, et al.
Publicado: (2013)

BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer Cells
por: Kim, Nam-Hee, et al.
Publicado: (2015)

Early Growth Response 4 Is Involved in Cell Proliferation of Small Cell Lung Cancer through Transcriptional Activation of Its Downstream Genes
por: Matsuo, Taisuke, et al.
Publicado: (2014)

The survival and proliferation of osteosarcoma cells are dependent on the mitochondrial BIG3‐PHB2 complex formation
por: Toki, Shunichi, et al.
Publicado: (2021)

A-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cells
por: Yoshimaru, Tetsuro, et al.
Publicado: (2017)

Multiplex Mutation Screening of the BRCA1 Gene in 1000 Japanese Breast Cancers
por: Emi, Mitsuru, et al.
Publicado: (1998)

Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells()()
por: Deng, Boya, et al.
Publicado: (2018)

Protein kinase A inhibition facilitates the antitumor activity of xanthohumol, a valosin‐containing protein inhibitor
por: Shikata, Yuki, et al.
Publicado: (2017)

Overexpression of C16orf74 is involved in aggressive pancreatic cancers
por: Nakamura, Toru, et al.
Publicado: (2016)

Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family
por: Lin, Meng-Lay, et al.
Publicado: (2007)

FZD10‐targeted α‐radioimmunotherapy with (225)Ac‐labeled OTSA101 achieves complete remission in a synovial sarcoma model
por: Sudo, Hitomi, et al.
Publicado: (2021)

Genetic Landscape of Chronic Myeloid Leukemia and a Novel Targeted Drug for Overcoming Resistance
por: Yoshimaru, Ryo, et al.
Publicado: (2023)

Targeting JWA for Cancer Therapy: Functions, Mechanisms and Drug Discovery
por: Ding, Kun, et al.
Publicado: (2022)

Roles and Mechanisms of Deubiquitinases (DUBs) in Breast Cancer Progression and Targeted Drug Discovery
por: Li, Sixuan, et al.
Publicado: (2021)

Targeting autophagic pathways for cancer drug discovery
por: Liu, Bo, et al.
Publicado: (2013)

Targeting transcription factors in cancer drug discovery
por: Mitra, Partha
Publicado: (2020)

The Discovery of New Drug-Target Interactions for Breast Cancer Treatment
por: Song, Jiali, et al.
Publicado: (2021)

Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy
por: Park, Jae-Hyun, et al.
Publicado: (2016)

Drug Normalization for Cancer Therapeutic and Druggable Genome Target Discovery
por: Jiang, Guoqian, et al.
Publicado: (2015)

Structural genomics and drug discovery
por: Lundstrom, K
Publicado: (2007)

Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls
por: Momozawa, Yukihide, et al.
Publicado: (2018)

Proteomics and genomics: perspectives on drug and target discovery
por: Ahn, Natalie G, et al.
Publicado: (2008)

Artificial intelligence in cancer target identification and drug discovery
por: You, Yujie, et al.
Publicado: (2022)

Drug Discovery and Development Targeting Dementia
por: Zagórska, Agnieszka, et al.
Publicado: (2023)

Functionalized liposomes for targeted breast cancer drug delivery
por: Nel, Janske, et al.
Publicado: (2023)

Voltage-gated calcium channels: Their discovery, function and importance as drug targets
por: Dolphin, Annette C.
Publicado: (2018)

Identification of an HLA-A2-Restricted Epitope Peptide Derived from Hypoxia-Inducible Protein 2 (HIG2)
por: Yoshimura, Sachiko, et al.
Publicado: (2014)

Functional genomics in virology and antiviral drug discovery
por: DeFilippis, Victor, et al.
Publicado: (2003)

The prediction models for postoperative overall survival and disease‐free survival in patients with breast cancer
por: Shigemizu, Daichi, et al.
Publicado: (2017)

Patient-derived tumour xenografts for breast cancer drug discovery
por: Cassidy, John W, et al.
Publicado: (2016)

Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment
por: Masci, Domiziana, et al.
Publicado: (2023)

Functional genomics approaches to improve pre‐clinical drug screening and biomarker discovery
por: Nguyen, Long V, et al.
Publicado: (2021)

Aiming drug discovery at lysophosphatidic acid targets
por: Tigyi, Gabor
Publicado: (2010)

Glutamate racemase as a target for drug discovery
por: Fisher, Stewart L.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_3barq9vr2lr05fvp0mh0221qib